NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002870,High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer,https://clinicaltrials.gov/study/NCT00002870,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs to kill more tumor cells. It is not yet known if high dose chemotherapy plus peripheral stem cell transplantation is more effective than standard therapy for breast cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of high dose chemotherapy plus peripheral stem cell transplantation with that of standard therapy in treating women who have locally recurrent or metastatic breast cancer.",NO,Breast Cancer,BIOLOGICAL: filgrastim|DRUG: cyclophosphamide|DRUG: epirubicin hydrochloride|DRUG: fluorouracil|DRUG: thiotepa|PROCEDURE: peripheral blood stem cell transplantation,"Disease free survival, 5 years",,,UNICANCER,,FEMALE,ADULT,PHASE3,180,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,PEGASE03|FRE-FNCLCC-PEGASE03|EU-96032,1994-12,2002-01,2002-01,2004-05-12,,2014-12-16,"Centre Paul Papin, Angers, 49036, France|CHR de Besancon - Hopital Jean Minjoz, Besancon, 25030, France|Clinique Saint Vincent, Besancon, 25044, France|Institut Bergonie, Bordeaux, 33076, France|C.H. Bourg En Bresse, Bourg En Bresse, 01012, France|C.H.U. de Brest, Brest, 29200, France|Centre Hospitalier General, Brive, France|Centre Regional Francois Baclesse, Caen, 14076, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Hopital Louis Pasteur, Colmar, 68024, France|Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, 21079, France|Institut Prive de Cancerologie, Grenoble, 38100, France|Centre Oscar Lambret, Lille, 59020, France|Centre Leon Berard, Lyon, 69373, France|Institut J. Paoli and I. Calmettes, Marseille, 13273, France|Hopital Notre-Dame de Bon Secours, Metz, 55038, France|Hopital Sainte Blandine, Metz, 57045, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, 34298, France|Centre Antoine Lacassagne, Nice, 06189, France|Hopital Saint-Louis, Paris, 75475, France|Federation Nationale des Centres de Lutte Contre le Cancer, Paris, 75654, France|Hopital Tenon, Paris, 75970, France|Hopital Haut Leveque, Pessac, 33604, France|Hopital Jean Bernard, Poitiers, 86021, France|Institut Jean Godinot, Reims, 51056, France|Centre Eugene Marquis, Rennes, 35062, France|C.H.U. Saint Etienne Hospital Nord, Saint Etienne, 42055, France|Hopitaux Universitaire de Strasbourg, Strasbourg, 67091, France|Institut Claudius Regaud, Toulouse, 31052, France|Centre Hospitalier Universitaire Bretonneau de Tours, Tours, 37044, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, 54511, France|CHRU de Nancy - Hopitaux de Brabois, Vandoeuvre-Les-Nancy, 54511, France",
